Primary Purpose
| primary_purpose | Study_Count |
|---|---|
| Treatment | 432 |
| Prevention | 22 |
| Basic Science | 15 |
| Supportive Care | 10 |
| Other | 8 |
| NA | 7 |
| Diagnostic | 6 |
| Health Services Research | 3 |
Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD
See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG
To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html
| Type | Study_count |
|---|---|
| Total_Studies | 583 |
| interventional | 503 |
| Observational | 72 |
| Registry | 8 |
```
| intervention_type | Study_Count |
|---|---|
| Drug | 181 |
| Drug|placebo | 154 |
| Other | 34 |
| Biological|placebo | 23 |
| Device | 15 |
| Biological | 13 |
| Behavioral | 11 |
| Device|Drug | 11 |
| Drug|Other | 11 |
| Dietary Supplement|placebo | 10 |
| Dietary Supplement | 7 |
| Drug|Other|placebo | 4 |
| Other|placebo | 4 |
| Procedure | 4 |
| Device|placebo | 3 |
| Behavioral|Drug | 2 |
| Behavioral|Other | 2 |
| Device|Other | 2 |
| Behavioral|Drug|Other | 1 |
| Biological|Drug | 1 |
| Biological|Drug|placebo | 1 |
| Biological|Other|placebo | 1 |
| Combination Product|Drug | 1 |
| Device|Drug|Other | 1 |
| Diagnostic Test | 1 |
| Dietary Supplement|Other | 1 |
| Genetic | 1 |
| Other|Procedure | 1 |
| placebo | 1 |
| Radiation | 1 |
| Country | Study_Count |
|---|---|
| United States | 157 |
| Germany | 41 |
| NA | 20 |
| United Kingdom | 19 |
| United States|Canada | 18 |
| Japan | 17 |
| Korea, Republic of | 12 |
| Canada | 9 |
| Taiwan | 9 |
| China | 8 |
| France | 8 |
| Netherlands | 7 |
| Sweden | 6 |
| Switzerland | 6 |
| Denmark | 5 |
| South Africa | 5 |
| Spain | 5 |
| Brazil | 4 |
| Italy | 4 |
| Australia | 3 |
| Finland | 3 |
| Norway | 3 |
| Singapore | 3 |
| Thailand | 3 |
| Austria | 2 |
| Belgium|Germany | 2 |
| Estonia|France|Lithuania|Poland|Romania | 2 |
| Germany|Netherlands | 2 |
| Ireland | 2 |
| Israel | 2 |
| Mexico | 2 |
| Russian Federation | 2 |
| United States|Australia|Canada | 2 |
| United States|Canada|Japan | 2 |
| United States|Canada|Puerto Rico | 2 |
| United States|Germany|Poland | 2 |
| United States|Japan | 2 |
| United States|Netherlands | 2 |
| Argentina|Australia|Austria|Brazil|Czechia|France|Germany|Hungary|India|Israel|Japan|Mexico|Poland|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom | 1 |
| Argentina|Australia|Austria|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|Taiwan | 1 |
| Argentina|Australia|Austria|Hungary|Israel|Japan|Korea, Republic of|Poland|Spain|Switzerland | 1 |
| Australia|Austria|Belgium|Bulgaria|Germany|Netherlands|Romania|South Africa | 1 |
| Australia|Belgium|Germany|Hungary|Iceland|Malta|Poland|Portugal | 1 |
| Australia|Germany|New Zealand | 1 |
| Austria|Argentina|Australia|Czechia|Denmark|France|Germany|Hungary|India|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Switzerland|Taiwan | 1 |
| Austria|France|Germany | 1 |
| Austria|Germany | 1 |
| Belgium | 1 |
| Belgium|Czechia|France|Germany|Poland|Spain|United Kingdom | 1 |
| Belgium|Denmark|Finland|France|Germany|Hungary|Ireland|Latvia|Netherlands|Poland|Spain|United Kingdom | 1 |
| Belgium|Germany|Poland|United Kingdom | 1 |
| Bulgaria|Denmark|Poland | 1 |
| Bulgaria|Finland|Germany | 1 |
| Canada|Denmark|Finland|United Kingdom | 1 |
| Canada|Finland|Germany | 1 |
| Canada|Israel | 1 |
| Chile | 1 |
| China|Philippines | 1 |
| Czechia|France|Germany|Hungary|Poland | 1 |
| Czechia|United States|Canada|Germany|Hungary|Japan|Poland | 1 |
| Dominican Republic | 1 |
| Egypt | 1 |
| France|Germany | 1 |
| France|Germany|Poland|United Kingdom | 1 |
| France|United States|Australia|Canada|Estonia|Korea, Republic of|Latvia|Lithuania|Spain | 1 |
| Germany|Czechia|Denmark|France|India|Italy|Japan|Mexico|Russian Federation|Taiwan | 1 |
| Germany|France|United States|Australia|Canada|Poland | 1 |
| Germany|Hungary|Poland | 1 |
| Germany|Spain|Belgium|United States|Canada|Czechia|France|Italy|Japan|Poland|United Kingdom | 1 |
| Germany|United States|Denmark | 1 |
| Germany|United States|France|Japan|Spain | 1 |
| Hungary | 1 |
| Hungary|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|Chile|China|Czechia|Germany|Israel|Italy|Japan|Korea, Republic of|Latvia|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan|United Kingdom | 1 |
| India | 1 |
| Indonesia | 1 |
| Italy|Germany|United States|Bulgaria|Canada|Mexico|Romania|Singapore|Taiwan|Ukraine | 1 |
| Japan|Austria|Belgium|Brazil|Finland|France|Germany|Italy|Netherlands|Poland|Russian Federation|Spain|Switzerland|United Kingdom | 1 |
| Japan|United States|Australia|Canada|Czechia|Hungary|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Romania|Spain|United Kingdom | 1 |
| Mexico|Venezuela | 1 |
| Mongolia | 1 |
| Philippines | 1 |
| Poland | 1 |
| Poland|United Kingdom|Canada|Czech Republic|Germany|Hungary | 1 |
| Poland|United States|Australia|Bulgaria|Canada|China|Czechia|Germany|Hungary|Japan|Korea, Republic of|Latvia|United Kingdom | 1 |
| Portugal | 1 |
| Spain|United States|Australia|Canada|Czechia|Estonia|Germany|Hungary|Japan|Korea, Republic of|Latvia|Poland|Switzerland|Ukraine|United Kingdom | 1 |
| United Kingdom|Austria|Belgium|Germany|Ireland|Netherlands|Poland|Russian Federation|Slovakia|Spain | 1 |
| United States|American Samoa|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|Denmark|France|Germany|Greece|Hungary|Ireland|Italy|Korea, Republic of|Netherlands|New Zealand|Portugal|Singapore|Spain|Taiwan|United Kingdom | 1 |
| United States|Argentina|Australia|Bosnia and Herzegovina|Bulgaria|Canada|China|Colombia|Croatia|Denmark|Estonia|Finland|France|Germany|Italy|Japan|Malaysia|New Zealand|Puerto Rico|Romania|Russian Federation|Switzerland|Turkey|Ukraine|United Kingdom | 1 |
| United States|Argentina|Austria|Belgium|Canada|Czechia|Estonia|Finland|France|Germany|Hungary|Iceland|Japan|Netherlands|Poland|Russian Federation|Slovakia|Taiwan|United Kingdom | 1 |
| United States|Argentina|Belgium|Brazil|Bulgaria|Canada|Chile|China|Germany|Israel|Italy|Latvia|Mexico|Netherlands|Poland|Romania|Russian Federation|Serbia|Slovakia|Spain|Taiwan | 1 |
| United States|Australia | 1 |
| United States|Australia|Austria|Belgium|Bulgaria|Canada|China|Czechia|Denmark|Estonia|Finland|France|Germany|Hungary|Ireland|Italy|Japan|Korea, Republic of|Lithuania|Netherlands|New Zealand|Poland|Romania|Russian Federation|Singapore|Slovakia|Spain|United Kingdom | 1 |
| United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Japan|Netherlands|New Zealand|Norway|Puerto Rico|Slovakia|Spain|Sweden|United Kingdom | 1 |
| United States|Australia|Austria|Canada|China|Spain|Turkey | 1 |
| United States|Australia|Austria|Canada|Czechia|Germany|Korea, Republic of|Latvia|Lithuania|Netherlands|New Zealand|Spain|United Kingdom | 1 |
| United States|Australia|Belgium|Canada|Finland|Germany|Japan|Netherlands|Spain | 1 |
| United States|Australia|Belgium|Canada|France|Germany|Japan|Netherlands|Poland|United Kingdom | 1 |
| United States|Australia|Bulgaria|Canada|Chile|Czechia|Germany|Hungary|Italy|Japan|Korea, Republic of|Latvia|Mexico|Poland|Slovakia|Spain|Taiwan|United Kingdom | 1 |
| United States|Australia|Bulgaria|Canada|Denmark|Germany|Hungary|Japan|Latvia|Poland | 1 |
| United States|Australia|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Malaysia|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Sweden|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Australia|Canada|Croatia|Czechia|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Malaysia|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Taiwan|Ukraine|United Kingdom | 1 |
| United States|Australia|Canada|Czechia|Finland|France|Germany|Korea, Republic of|Netherlands|Poland|Spain|Switzerland|Taiwan|United Kingdom | 1 |
| United States|Australia|Canada|Czechia|Germany|Hungary|Japan|Korea, Republic of|Poland|Spain|United Kingdom | 1 |
| United States|Australia|Canada|Czechia|Germany|Hungary|Poland|United Kingdom | 1 |
| United States|Australia|Canada|Denmark|Italy|Korea, Republic of|Poland|Russian Federation|United Kingdom | 1 |
| United States|Australia|Canada|Germany|Hungary | 1 |
| United States|Australia|Canada|Germany|Hungary|New Zealand | 1 |
| United States|Australia|Canada|Germany|Japan|Poland | 1 |
| United States|Australia|Canada|Japan|Puerto Rico | 1 |
| United States|Australia|China|Czechia|Germany|Hungary|Italy|Japan|Latvia|Mexico|Poland|Spain|Taiwan|United Kingdom | 1 |
| United States|Australia|China|New Zealand | 1 |
| United States|Australia|Germany|Israel|Spain|Switzerland|United Arab Emirates | 1 |
| United States|Australia|Germany|Poland|United Kingdom | 1 |
| United States|Australia|New Zealand | 1 |
| United States|Australia|Poland | 1 |
| United States|Belgium|Bulgaria|Estonia|France|Germany|Hungary|Italy|Korea, Republic of|Poland|Romania|Singapore | 1 |
| United States|Belgium|Canada|Germany|Netherlands|Poland|Spain|United Kingdom | 1 |
| United States|Belgium|Czechia|Germany|Korea, Republic of|Poland|Spain | 1 |
| United States|Belgium|Germany|Italy|Poland|Sweden|Switzerland|United Kingdom | 1 |
| United States|Bulgaria|Canada|Czechia|Germany|Lithuania|Poland | 1 |
| United States|Bulgaria|Canada|Czechia|Germany|Poland|Spain | 1 |
| United States|Canada|Czechia|Germany|Hungary|Poland|United Kingdom | 1 |
| United States|Canada|Finland|Germany|Iceland|Japan|Netherlands|Poland|Russian Federation|Slovakia|United Kingdom | 1 |
| United States|Canada|France|Germany|Hungary|Italy|Poland | 1 |
| United States|Canada|Germany | 1 |
| United States|Canada|Germany|Japan | 1 |
| United States|Canada|South Africa | 1 |
| United States|Dominican Republic|Honduras | 1 |
| United States|France|Netherlands | 1 |
| United States|Germany | 1 |
| United States|Germany|Italy|Japan|Netherlands|Switzerland | 1 |
| United States|Honduras|Panama | 1 |
| United States|Mexico | 1 |
| United States|Norway|Puerto Rico | 1 |
| United States|Poland | 1 |
| United States|Poland|Canada|Czechia|Germany|United Kingdom | 1 |
| United States|South Africa | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 239 |
| 2 | 35 |
| 3 | 23 |
| 4 | 13 |
| 5 | 13 |
| 6 | 10 |
| 7 | 11 |
| 8 | 3 |
| 9 | 6 |
| 10 | 7 |
| 11 | 3 |
| 12 | 5 |
| 13 | 11 |
| 14 | 2 |
| 15 | 5 |
| 16 | 2 |
| 17 | 4 |
| 18 | 2 |
| 19 | 4 |
| 20 | 3 |
| 21 | 1 |
| 22 | 5 |
| 23 | 1 |
| 24 | 1 |
| 25 | 2 |
| 26 | 2 |
| 27 | 4 |
| 28 | 2 |
| 29 | 2 |
| 30 | 1 |
| 31 | 4 |
| 32 | 1 |
| 33 | 1 |
| 35 | 2 |
| 36 | 1 |
| 38 | 3 |
| 40 | 1 |
| 41 | 1 |
| 42 | 2 |
| 43 | 2 |
| 44 | 1 |
| 45 | 1 |
| 47 | 1 |
| 49 | 1 |
| 51 | 1 |
| 52 | 2 |
| 53 | 1 |
| 57 | 2 |
| 58 | 1 |
| 60 | 3 |
| 63 | 1 |
| 64 | 1 |
| 66 | 4 |
| 67 | 1 |
| 68 | 1 |
| 70 | 1 |
| 72 | 2 |
| 73 | 1 |
| 74 | 1 |
| 75 | 1 |
| 76 | 1 |
| 79 | 1 |
| 80 | 1 |
| 81 | 1 |
| 84 | 2 |
| 87 | 1 |
| 88 | 1 |
| 89 | 1 |
| 90 | 2 |
| 93 | 1 |
| 97 | 1 |
| 102 | 1 |
| 103 | 1 |
| 114 | 1 |
| 115 | 2 |
| 121 | 2 |
| 123 | 1 |
| 136 | 1 |
| 149 | 1 |
| 153 | 1 |
| 159 | 1 |
| 166 | 1 |
| 181 | 1 |
| 185 | 1 |
| 192 | 1 |
| 196 | 1 |
| 216 | 1 |
| 242 | 1 |
| 289 | 1 |
| 434 | 1 |
| 496 | 1 |
| Phase | Study_Count |
|---|---|
| Phase 2 | 171 |
| Phase 3 | 99 |
| N/A | 97 |
| Phase 4 | 64 |
| Phase 1 | 46 |
| Phase 1/Phase 2 | 19 |
| Early Phase 1 | 4 |
| Phase 2/Phase 3 | 3 |
| Number_of_Arms | Count_of_Studies |
|---|---|
| 1 | 76 |
| 2 | 238 |
| 3 | 70 |
| 4 | 54 |
| 5 | 15 |
| 6 | 11 |
| 7 | 3 |
| 8 | 5 |
| 9 | 2 |
| 11 | 1 |
| 13 | 2 |
| 14 | 1 |
| 27 | 1 |
| NA | 24 |
| Measure | Early.Phase.1 | N.A | Phase.1 | Phase.1.Phase.2 | Phase.2 | Phase.2.Phase.3 | Phase.3 | Phase.4 |
|---|---|---|---|---|---|---|---|---|
| Min. | 40.0 | 4.0000 | 5.00000 | 23.00000 | 5.0000 | 48.00000 | 20.0000 | 5.00000 |
| 1st Qu. | 44.5 | 23.7500 | 26.25000 | 35.00000 | 48.0000 | 69.00000 | 200.0000 | 29.75000 |
| Median | 48.0 | 56.0000 | 40.00000 | 54.00000 | 103.0000 | 90.00000 | 364.0000 | 50.00000 |
| Mean | 48.0 | 128.3542 | 81.28261 | 63.10526 | 137.3018 | 79.33333 | 514.8866 | 98.93333 |
| 3rd Qu. | 51.5 | 101.2500 | 77.25000 | 67.00000 | 204.0000 | 95.00000 | 740.0000 | 117.75000 |
| Max. | 56.0 | 2701.0000 | 800.00000 | 221.00000 | 640.0000 | 100.00000 | 3000.0000 | 600.00000 |
| group_type | Group_Count |
|---|---|
| Experimental | 764 |
| Placebo Comparator | 257 |
| Active Comparator | 184 |
| Other | 40 |
| No Intervention | 28 |
| NA | 24 |
| Sham Comparator | 3 |
| intervention_model | Study_Count |
|---|---|
| Parallel Assignment | 360 |
| Single Group Assignment | 105 |
| Crossover Assignment | 20 |
| Sequential Assignment | 11 |
| Factorial Assignment | 5 |
| NA | 2 |
| primary_purpose | Study_Count |
|---|---|
| Treatment | 432 |
| Prevention | 22 |
| Basic Science | 15 |
| Supportive Care | 10 |
| Other | 8 |
| NA | 7 |
| Diagnostic | 6 |
| Health Services Research | 3 |
| Country | Study_Count |
|---|---|
| United States | 41 |
| NA | 4 |
| Germany | 3 |
| Korea, Republic of | 3 |
| Netherlands | 2 |
| Thailand | 2 |
| United Kingdom | 2 |
| Austria | 1 |
| Canada | 1 |
| Denmark | 1 |
| Finland | 1 |
| Hong Kong | 1 |
| Indonesia | 1 |
| Indonesia|Singapore | 1 |
| Kazakhstan | 1 |
| Lithuania | 1 |
| Poland | 1 |
| Russian Federation | 1 |
| Singapore | 1 |
| Switzerland | 1 |
| Taiwan | 1 |
| United States|Canada|Chile|Hong Kong|Italy|Netherlands | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 60 |
| 2 | 7 |
| 4 | 1 |
| 7 | 2 |
| 9 | 1 |
| 14 | 1 |
| Measure | Observational |
|---|---|
| Min | 9.00 |
| 1st Qu | 45.00 |
| Median | 80.00 |
| Mean | 20925.18 |
| 3rd Qu | 404.50 |
| Max | 1027559.00 |
| observational_model | Study_Count |
|---|---|
| Cohort | 25 |
| Case-Control | 12 |
| Case-Only | 11 |
| NA | 9 |
| Case Control | 6 |
| Other | 5 |
| Ecologic or Community | 2 |
| Defined Population, Natural History | 1 |
| Family-Based | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 49 |
| Cross-Sectional | 10 |
| Retrospective | 7 |
| Other | 2 |
| NA | 2 |
| Cross-Sectional, Prospective | 1 |
| Longitudinal, Retrospective | 1 |
| Country | Study_Count |
|---|---|
| Netherlands | 3 |
| United States | 3 |
| China | 1 |
| Germany | 1 |
| Site_count | Study_Count |
|---|---|
| 1 | 5 |
| 3 | 1 |
| 11 | 1 |
| 38 | 1 |
| Measure | Registries |
|---|---|
| Min | 21.000 |
| 1st Qu | 156.250 |
| Median | 493.500 |
| Mean | 2254.125 |
| 3rd Qu | 750.000 |
| Max | 15000.000 |
| observational_model | Study_Count |
|---|---|
| Cohort | 6 |
| Case-Only | 1 |
| Other | 1 |
| time_perspective | Study_Count |
|---|---|
| Prospective | 7 |
| Other | 1 |
| target_duration | Study_Count |
|---|---|
| 5 Years | 3 |
| 1 Year | 1 |
| 10 Years | 1 |
| 12 Months | 1 |
| 2 Years | 1 |
| 3 Years | 1 |
#If less then 500 trials
#If less then 500 studies
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT01569906 | Narrowband UVB for Children With Moderate to Severe Atopic Eczema | https://ClinicalTrials.gov/show/NCT01569906 | Completed | Royal Victoria Infirmary | 2010-08-31 |
| NCT01714245 | A Study to Evaluate CLn® BodyWash As Added Therapy in Eczema Patients | https://ClinicalTrials.gov/show/NCT01714245 | Completed | TopMD Skin Care, Inc. | 2013-12-31 |
| NCT03831646 | Clinical, Psychological and Genetic Characteristics in Dermatological Patients | https://ClinicalTrials.gov/show/NCT03831646 | Completed | Astana Medical University | 2019-07-10 |
| NCT03823794 | Trends in the Epidemiology and Treatment of Atopic Dermatitis in the United Kingdom (UK) | https://ClinicalTrials.gov/show/NCT03823794 | Active, not recruiting | Momentum Data | 2020-05-01 |
| NCT03361215 | Disease Trajectories in Atopic Dermatitis and Psoriasis | https://ClinicalTrials.gov/show/NCT03361215 | Recruiting | University of Schleswig-Holstein | 2027-01-01 |
| NCT03252340 | Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03252340 | Active, not recruiting | EHL Bio Co., Ltd. | 2021-08-17 |
| NCT03168113 | Atopic Dermatitis (AD) and Food Allergy | https://ClinicalTrials.gov/show/NCT03168113 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-01-31 |
| NCT03142139 | Does Timeliness of DTaP-IPV-Hib Vaccination Affect Development of Atopic Dermatitis Before 1 Year of Age? | https://ClinicalTrials.gov/show/NCT03142139 | Completed | Bandim Health Project | 2014-12-31 |
| NCT03112876 | Sebum Collection and Skin Barrier Function Analysis | https://ClinicalTrials.gov/show/NCT03112876 | Completed | University of California, Davis | 2016-02-26 |
| NCT03003793 | Insulin Sensitivity in Patients With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03003793 | Completed | University Hospital, Gentofte, Copenhagen | 2016-09-30 |
| NCT02926807 | Trial on Vascular Inflammation in Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT02926807 | Completed | Innovaderm Research Inc. | 2018-11-30 |
| NCT02916888 | A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists | https://ClinicalTrials.gov/show/NCT02916888 | Completed | Yale University | 2017-12-31 |
| NCT02680405 | Identification of Epidermal Signatures in Patients With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT02680405 | Active, not recruiting | National Jewish Health | 2016-07-31 |
| NCT03038932 | Etiology of Eczema Herpeticum (EH) | https://ClinicalTrials.gov/show/NCT03038932 | Recruiting | National Institute of Allergy and Infectious Diseases (NIAID) | 2020-08-31 |
| NCT00605878 | Studies of Skin Microbes in Healthy People and in People With Skin Conditions | https://ClinicalTrials.gov/show/NCT00605878 | Recruiting | National Institutes of Health Clinical Center (CC) | NA |
| NCT02552979 | Atopy Patch Test in Children With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT02552979 | Completed | Mahidol University | 2014-12-31 |
| NCT02532920 | The Natural History of Atopic Disease in Thai Children and Association With Atopic March | https://ClinicalTrials.gov/show/NCT02532920 | Completed | Mahidol University | 2016-06-30 |
| NCT02401178 | The Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in Infants | https://ClinicalTrials.gov/show/NCT02401178 | Completed | Indonesia University | 2015-12-31 |
| NCT02125695 | Pilot Tape Harvesting Study | https://ClinicalTrials.gov/show/NCT02125695 | Completed | Biogen | 2016-08-31 |
| NCT02098551 | Skin Testing With Recombinant Bet v 1 and Hypoallergenic Recombinant Bet v 1 Fragments | https://ClinicalTrials.gov/show/NCT02098551 | Completed | Medical University of Vienna | 2011-11-30 |
| NCT02091037 | S. Aureus Colonization in Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT02091037 | Active, not recruiting | Columbia University | 2016-12-31 |
| NCT02073591 | Correlation Study Between PEST and SCORAD in Management of Atopic Dermatitis With Ceradan® Regimen | https://ClinicalTrials.gov/show/NCT02073591 | Completed | Hyphens Pharma Pte Ltd | 2014-11-30 |
| NCT01931644 | At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions | https://ClinicalTrials.gov/show/NCT01931644 | Recruiting | Sanguine Biosciences | 2025-08-31 |
| NCT04240522 | Prospective Longitudinal Observational Research in Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT04240522 | Recruiting | University of Zurich | 2020-01-20 |
| NCT01789619 | Extended Release Tacrolimus (Advagraf®) in Severe Adult Atopic Dermatitis Patients | https://ClinicalTrials.gov/show/NCT01789619 | Completed | UMC Utrecht | 2014-01-31 |
| NCT01494142 | Registry for the Atopic Dermatitis Research Network | https://ClinicalTrials.gov/show/NCT01494142 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2018-02-07 |
| NCT01429311 | Interferon Responses in Eczema Herpeticum | https://ClinicalTrials.gov/show/NCT01429311 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2016-01-31 |
| NCT04362852 | Patient Forward Access to Clinical and Technological Research: Genetic Influences on Lung Cancer and Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT04362852 | Recruiting | Boston Children’s Hospital | 2021-02-01 |
| NCT04354207 | Vitamin D and Its Receptor Gene Polymorphisms in Lithuanian, Latvian and Taiwanese Patients With Atopic Dermatitis and Asthma | https://ClinicalTrials.gov/show/NCT04354207 | Enrolling by invitation | Lithuanian University of Health Sciences | 2022-08-01 |
| NCT03490877 | Scratch and Sleep Quantification in Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03490877 | Completed | University of Rochester | 2019-04-30 |
| NCT04276623 | Identifying Atopic Dermatitis Patients at Risk for Developing Conjunctivitis During Dupilumab Treatment | https://ClinicalTrials.gov/show/NCT04276623 | Recruiting | UMC Utrecht | 2022-09-01 |
| NCT04218877 | The Factors Affecting Atopic Dermatitis in Children Age 1-3 | https://ClinicalTrials.gov/show/NCT04218877 | Recruiting | Akusherstvo Pro | 2020-07-10 |
| NCT04180644 | Skin Tape Transcriptome Methods in Children | https://ClinicalTrials.gov/show/NCT04180644 | Completed | National Jewish Health | 2020-02-05 |
| NCT04154839 | Epidemiological Survey and Genetic Analysis of AD Patients in Hong Kong | https://ClinicalTrials.gov/show/NCT04154839 | Recruiting | The University of Hong Kong | 2021-12-31 |
| NCT01995747 | The Effect of Anti-CεmX on IgE Production | https://ClinicalTrials.gov/show/NCT01995747 | Completed | National Taiwan University Hospital | 2012-06-30 |
| NCT04097327 | Effect of Ectoin Dermatitis Cream 7% on Skin Hydration and Skin Barrier Function | https://ClinicalTrials.gov/show/NCT04097327 | Completed | Bitop AG | 2019-12-31 |
| NCT04087863 | Administration for Placebo Group and Evalution the Safety and Efficacy in Atopic Dermatitis Patients | https://ClinicalTrials.gov/show/NCT04087863 | Recruiting | Kang Stem Biotech Co., Ltd. | 2022-12-31 |
| NCT04060550 | Impact of Increased Immunoglobulin E to Anti-herpes Simplex Virus -1 Innate Immune Responses in Atopic Dermatitis Patients With Eczema Herpeticum | https://ClinicalTrials.gov/show/NCT04060550 | Recruiting | National Jewish Health | 2020-09-01 |
| NCT04008784 | Improvement of Short Term Outcome of Mild to Moderate Atopic Dermatitis Using a Combination of Crisaborole and a Concomitant Topical Corticosteroid Over a 8 Week Period | https://ClinicalTrials.gov/show/NCT04008784 | Recruiting | Clinical Research Center of the Carolinas | 2020-02-29 |
| NCT03874039 | Sweat and Gas Sensor for Healthy Skin and Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03874039 | Recruiting | Northwestern University | 2020-12-31 |
| NCT03813472 | Hydration Sensor for Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03813472 | Enrolling by invitation | Northwestern University | 2021-04-30 |
| NCT03770858 | Wearable Skin Sensors to Assess Nocturnal Scratch Behavior | https://ClinicalTrials.gov/show/NCT03770858 | Recruiting | Northwestern University | 2021-09-30 |
| NCT03411837 | Dupilumab Phase 4 Study | https://ClinicalTrials.gov/show/NCT03411837 | Enrolling by invitation | Northwestern University | 2020-03-31 |
| NCT01238263 | Autologous Serum Skin Testing in Patients With Atopic Dermatitis Autologous Serum Skin Testing in Patients With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT01238263 | Completed | Yuzuncu Yıl University | 2010-06-30 |
| NCT01164241 | Natural History of Diseases Associated With Allergic Inflammation: Atopic Dermatitis and Genetic and Congenital Diseases Associated With Atopic Pathways | https://ClinicalTrials.gov/show/NCT01164241 | Recruiting | National Institutes of Health Clinical Center (CC) | NA |
| NCT01069666 | Knowledge Base in the Treatment of Atopic Dermatitis Among Thai Pediatricians | https://ClinicalTrials.gov/show/NCT01069666 | Completed | Siriraj Hospital | NA |
| NCT03559075 | Clinical vs. Anecdotal Evidence - Pediatric Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03559075 | Completed | Wake Forest University Health Sciences | 2018-08-08 |
| NCT00879944 | Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index | https://ClinicalTrials.gov/show/NCT00879944 | Completed | Northwestern University | 2012-06-30 |
| NCT00822276 | The Underlying Mechanisms For S. Aureus Infection And Colonization Of Skin in People With Atopic Dermatitis With And Without Eczema Herpeticum (MRSA) | https://ClinicalTrials.gov/show/NCT00822276 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-11-30 |
| NCT03962387 | Evalution the Safety and Efficacy in Atopic Dermatitis Patients | https://ClinicalTrials.gov/show/NCT03962387 | Recruiting | Kang Stem Biotech Co., Ltd. | 2024-01-02 |
| NCT00815984 | Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases | https://ClinicalTrials.gov/show/NCT00815984 | Completed | Medical Universtity of Lodz | 2010-01-31 |
| NCT01782703 | Defining the Skin and Blood Biomarkers of Pediatric Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT01782703 | Recruiting | Northwestern University | 2020-12-31 |
| NCT03800004 | Bone Health in Patients With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03800004 | Recruiting | Mayo Clinic | 2020-12-30 |
| NCT00713089 | Study of Stool Microbiota in Two Diverse Cohorts of Asian and Its Influence on Allergy Development | https://ClinicalTrials.gov/show/NCT00713089 | Completed | National University Hospital, Singapore | 2009-11-30 |
| NCT00710489 | Potential Research Study Participant Registry | https://ClinicalTrials.gov/show/NCT00710489 | Completed | University of California, Davis | 2018-09-05 |
| NCT00696397 | Comprehensive Investigation of Opiates, Neuropeptides, Barrier Function, Scratching and Sleep Physiology | https://ClinicalTrials.gov/show/NCT00696397 | Completed | Wake Forest University Health Sciences | 2009-12-31 |
| NCT00691366 | Comprehensive Investigation of Heart Rate Variability as a Measure of the Autonomic Nervous System in Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00691366 | Completed | Wake Forest University Health Sciences | 2009-12-31 |
| NCT00660127 | The Effect of Visual Stimuli on Itch Perception Intensity in Healthy and Atopic Dermatitis Patients | https://ClinicalTrials.gov/show/NCT00660127 | Completed | Wake Forest University Health Sciences | 2009-12-31 |
| NCT00568997 | 10 Year Registry of Children (Ages 2-17 Years) With Eczema That Have Used Pimecrolimus | https://ClinicalTrials.gov/show/NCT00568997 | Recruiting | Bausch Health Americas, Inc. | 2026-12-31 |
| NCT00515047 | Identifying Genetic Determinants of Eczema Herpeticum and Other Viral Infections in Individuals With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00515047 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2011-01-31 |
| NCT00459576 | Risk of Asthma in Infants With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00459576 | Completed | Indiana University | 2012-01-31 |
| NCT00438646 | Oral Bacteria and Allergic Disease in Children | https://ClinicalTrials.gov/show/NCT00438646 | Completed | National Institutes of Health Clinical Center (CC) | 2008-12-31 |
| NCT00438022 | Identifying Risk Factors for Eczema Herpeticum in Individuals With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00438022 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2010-01-31 |
| NCT00407979 | Comparison of Cathelicidin Expression in Skin and Saliva in Patients With Atopic Dermatitis and Psoriasis | https://ClinicalTrials.gov/show/NCT00407979 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-02-28 |
| NCT00406081 | Immune Response to Varicella Vaccination in Children With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00406081 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 2009-09-30 |
| NCT00379678 | Effects of Pimecrolimus on Skin Biopsy Ex-plants From Patients With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00379678 | Completed | National Jewish Health | 2007-03-31 |
| NCT00001760 | Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals | https://ClinicalTrials.gov/show/NCT00001760 | Completed | National Institutes of Health Clinical Center (CC) | NA |
| NCT00277433 | Histamine Pharmacogenetics in Children With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00277433 | Completed | Virginia Commonwealth University | 2009-12-31 |
| NCT00275795 | NAET Screening for Food Allergy, Sensitivity and Intolerances Using IgE-Specific Antigen Test and NST- NAET® | https://ClinicalTrials.gov/show/NCT00275795 | Completed | Nambudripad’s Allergy Research Foundation | NA |
| NCT00177268 | Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research | https://ClinicalTrials.gov/show/NCT00177268 | Recruiting | University of Pittsburgh | 2027-01-31 |
| NCT00795496 | Bronchial Hyperreactivity in Atopic Dermatitis Patients - a 10 Year Follow-up | https://ClinicalTrials.gov/show/NCT00795496 | Completed | University of Helsinki | 2010-04-30 |
| NCT00098150 | Follow-Up Study of Patients Previously Treated With Pimecrolimus Tablets for Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT00098150 | Completed | Novartis | NA |
#If less then 500 registries
| nct_id | brief_title | link | overall_status | source | primary_completion_date |
|---|---|---|---|---|---|
| NCT04462055 | Effectiveness of Dupilumab in Food Allergic Patients With Moderate to Severe Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT04462055 | Recruiting | UMC Utrecht | 2022-07-01 |
| NCT03661866 | A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for IMISC | https://ClinicalTrials.gov/show/NCT03661866 | Recruiting | Target PharmaSolutions, Inc. | 2026-10-31 |
| NCT03057860 | TREATgermany: German National Clinical Registry for Patients With Moderate-to-severe Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03057860 | Recruiting | Technische Universität Dresden | 2021-01-31 |
| NCT02889081 | Maternal Key Nutritional Factors and Offspring’s Atopic Dermatitis (MKNFOAD) | https://ClinicalTrials.gov/show/NCT02889081 | Completed | Children’s Hospital of Fudan University | 2017-10-31 |
| NCT04214548 | A Pilot Study to Explore the Role of Gut Flora in Eczema | https://ClinicalTrials.gov/show/NCT04214548 | Recruiting | ProgenaBiome | 2023-03-31 |
| NCT04017520 | Breast Milk: Influence of the Micro-transcriptome Profile on Atopy in Children and Toddlers | https://ClinicalTrials.gov/show/NCT04017520 | Recruiting | Milton S. Hershey Medical Center | 2021-04-30 |
| NCT03621137 | TREAT NL (TREatment of ATopic Eczema, the Netherlands) Registry: Dutch National Registry for Patients With Moderate-to-severe Atopic Eczema on Photo- or Systemic Therapies | https://ClinicalTrials.gov/show/NCT03621137 | Recruiting | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2027-10-31 |
| NCT03549416 | BioDay Registry: Data Collection Regarding the Use of New Systemic Treatment Options in Patients With Atopic Dermatitis | https://ClinicalTrials.gov/show/NCT03549416 | Recruiting | UMC Utrecht | 2028-12-31 |